| |
|
|
|
Cytosorbents Cor  
|
|
8.06 -0.26 (-0.03%) |
09-28 16:00 |
|
Open: |
8.11 |
Pre close: |
8.32 |
Target:
|
10.60 
|
|
High: |
8.08 |
Low: |
7.91 |
Resistance:
|
9.08
9.80
|
|
Volume: |
176,900 |
Market Cap: |
349M |
Support:
|
7.91
6.58
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.16
 |
MACD |
MACD(12,26):
|
-0.08 |
|
MA(20): |
8.70 |
Signal(12,26,9): |
0.03 |
|
MA(100): |
8.10 |
Stochastic Oscillator |
%K(14,3):
|
5.47 |
|
MA(250): |
8.61 |
%D(3): |
5.83 |
|
Average Volume(K) |
3-Month: |
1330558
|
52-Week |
High:
|
11.68 |
|
10-Days: |
22148 |
Low: |
6.99 |
|
RSI |
RSI(14):
|
41.63 |
Change(%): |
1.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.210 |
Return on Equity (ttm) |
-21.0 |
Shares Out. (M) |
43.32 |
|
EPS Est. Current Year |
-0.270 |
Return on Assets (ttm) |
-10.5 |
Shares Float (M) |
39.70 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.46 |
|
EPS Est. Next Quarter |
-0.110 |
Qtrly Rev. Growth |
22.8 |
% Held by Institutions |
43.50 |
|
Forward EPS |
-0.600 |
Gross Profit (p.s.) |
0.691 |
Shares Short (K) |
1940 |
|
Book Value (p.s.) |
1.780 |
EBITDA (p.s.) |
-0.272 |
P/E |
-38.38 |
|
Sales Per Share |
1.042 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.53 |
|
Profit Margin |
-22.97 |
Operating Cash Flow
(M) |
-8.72 |
P/S |
7.74 |
|
Operating Margin |
-27.41 |
Levered Free Cash Flow
(M) |
-7.39 |
P/CF |
-40.04 |
|
|
|
|
|
|
